[Four cases of benign hepatic tumors associated with oral contraception (author's transl)]

The authors have observed 4 cases of benign liver tumors associated with oral contraception. These lesions have been revealed by pains or abdominal tumors, and have been treated by surgery, or not treated. The relations between tumors livers and pill are studied. These tumors are probably frequent and can give acute complications such hemorrhage and perhaps cancer.

[Ischemic cardiovascular accidents during treatment with progestins alone. Apropos of 3 cases]

Three cases of ischaemic cardio-vascular accidents are reported under progestative treatment; the drug used was chlormadinone acétate (0,5 mg daily) in one patients, and noréthistérone (5 mg daily) in two others. The accident was observed in two cases at the end of the second menstrual cycle and in one case after three years. Lipid abnormalities have been detected in the three cases: minor type IV (two patients) and mixed hyperlipidaemia (one patient).

Proper management of hepatic adenoma associated with oral contraceptives

Four patients with oral contraceptive associated hepatic adenoma have been studied and the literature reviewed. Clinically, these patients can be divided into ruptured and nonruptured hepatoma groups. In instances of ruptured hepatomas, resection only sufficient to control hemorrhage definitely is recommended. In instances of nonruptured hepatomas, major resection should only be attempted by skilled surgeons, and small multiple lesions should be observed. These management principles will deserve re-evaluation as more experience with these tumors accumulates. Until then, a conservative approach is indicated. This includes the avoidance of oral contraception until the biochemistry of these tumors is better clarified.

[Influence of hormonal contraceptives upon carbohydrate metabolism in women with abnormal glucose assimilation during previous pregnancy (author's transl)]

Carbohydrate metabolism was examined--by means of the 100-gm-glucose standard tolerance test--in 23 patients showing a decrease in glucose tolerance during pregnancy; the examinations were carried out postpartum and after a three months' intake of a hormonal contraceptive (compound preparation: mestranol 0.1 mg, lynestrenol 1.0 mg). The peak values and the two-hour-values, being statistically significant, showed a normalization after delivery, and furthermore again a deterioration of glucose tolerance during the intake of the preparation. A remarkable increase in weight, as a possible cause for the dysbolism during contraception, was not observed.